ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

GOVXW GeoVax Labs Inc

0.035
0.0081 (30.11%)
2024年5月11日 - 終了
15分遅延
名称 銘柄コード 市場 種別
GeoVax Labs Inc GOVXW NASDAQ Equity Warrant
  前日比 前日比 % 現在値 時刻
0.0081 30.11% 0.035 08:59:59
始値 安値 高値 終値 前日終値
0.0269 0.0269 0.04284 0.035 0.0269
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0501:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
2024/3/2822:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
2024/3/1222:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
2024/3/0623:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
2024/3/0106:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
2024/2/2223:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
2024/2/1923:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
2024/2/1323:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
2024/2/0623:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
2024/1/2923:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
2024/1/0823:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
2024/1/0423:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
2024/1/0323:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
2023/12/2723:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
2023/12/1923:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
2023/12/0106:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
2023/11/2923:00GLOBEGeoVax to Participate in Upcoming December Investor Events
2023/11/2823:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
2023/11/1423:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
2023/11/0906:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
2023/10/3122:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
2023/10/3022:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
2023/10/2522:00GLOBEGeoVax to Participate in Upcoming November Investor and..
2023/10/2422:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
2023/10/0922:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
2023/10/0522:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
2023/9/2722:00GLOBEGeoVax to Participate in Upcoming October Investor and..
2023/9/2622:00GLOBEGeoVax Secures Multi-Product License for ProBioGen's..
2023/9/2022:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data Presented at..
2023/9/1922:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent..
2023/9/1222:00GLOBEGeoVax Presents Corporate Update at the H.C. Wainwright 25th..
2023/9/1122:00GLOBEGeoVax Completes Enrollment of Phase 2 Trial for..
2023/8/3122:00GLOBEGeoVax to Present at the H.C. Wainwright 25th Annual Global..
2023/8/2822:00GLOBEGeoVax Receives Notice of Allowance for Malaria Vaccine..
2023/8/1022:00GLOBEGeoVax Announces First Patients Vaccinated in Phase 2..
2023/8/1005:00GLOBEGeoVax Reports 2023 Second Quarter Financial Results and..
2023/7/2622:00GLOBEGeoVax to Report Second Quarter 2023 Financial Results and..
2023/7/2422:00GLOBEGeoVax Announces Issuance of Ebola Vaccine Patent
2023/7/2022:00GLOBEGeoVax Announces Initiation of Phase 2 Clinical Trial of..
2023/7/1022:00GLOBEGeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS..
2023/6/2822:00GLOBEGeoVax Announces Gedeptin® Presentation at the AACR-AHNS..
2023/6/2723:15GLOBEGeoVax Universal Coronavirus Vaccine Design & Development..
2023/5/3122:00GLOBEGeoVax Partners With ABL to Advance cGMP Production of..
2023/5/2522:00GLOBEGeoVax to Participate in Upcoming Industry Meetings
2023/5/2421:00GLOBEGeoVax’s Next-Generation COVID-19 Vaccine Shows High..
2023/5/1522:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data to be Presented..

最近閲覧した銘柄

Delayed Upgrade Clock